** Shares of life sciences firms Thermo Fisher Scientific TMO.N and Danaher DHR.N rise over 2% in premarket trade
** Franco-German peer Sartorius' SATG.DE Q4 orders in its key bioprocess solutions division (BPS) rose 23.1% to 856.7 million euros
** SATG also reports annual underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of 945 mln euros ($984.78 mln), topping a Vara consensus estimate of 932.7 mln
** With the significant orders beat and another quarter of sequential BPS order improvement, we view the SATG results as a positive data point for AVTR, DHR and TMO, and expect the group to trade well - brokerage Citi Research
** Shares of Avantor AVTR.N were up marginally premarket
** In 2024, AVTR fell 7.7%, DHR fell 0.8% and TMO fell 2%
($1 = 0.9596 euros)
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.